A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer
Clinical trial NCT07082179 · RECRUITING
Trial details
- NCT number
- NCT07082179
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-04
- Primary completion
- 2027-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.